Home » Topics » BioWorld Science

BioWorld Science
RSS

A mosaic HIV-1 vaccine is assessed in a phase I/IIa trial and in rhesus monkeys

July 17, 2018

A designer supramolecule AK-750 amplifies innate immune responses in preclinical models of cancer

July 17, 2018

Specific redox enzyme helps reverse fibrosis

July 17, 2018

Aging, ARCH and AML

July 17, 2018

Cognitive, somatic stabilization by treatment with IgG-IDUA fusion protein in children with MPS I

July 17, 2018

MaxCyte's cleared to begin clinical study of CAR therapy MCY-M11

July 16, 2018

First-in-human study explores use of BAY-2287411 in mesothelin-expressing tumors

July 16, 2018

Brain-targeted gene editing using CRISPR-Gold in mice models of fragile X syndrome

July 16, 2018

BGI-Shenzhen synthesizes new cancer vaccines

July 16, 2018

RegenxBio begins first-in-human study with RGX-121 gene therapy for Hunter's syndrome

July 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...